✨ Medicines Consent Notices
NEW ZEALAND GAZETTE, No. 175
23 DECEMBER 2004
Product:
Active Ingredient:
Poly-O-(2-hydroxyethyl)-starch 6%w/v
Dosage Form:
Solution for injection
New Zealand Sponsor:
Biomed Limited
Manufacturer:
Biomed Limited, Pt Chevalier, Auckland
Product:
Hemohes
Product:
Active Ingredient:
Levetiracetam 1,000mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Muir Hutchison Limited
Manufacturer:
UCB S.A., Chemin du Foriest, Braine-l’Alleud, Brussels, Belgium
Product:
Keppra
Product:
Active Ingredient:
Levetiracetam 250mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Muir Hutchison Limited
Manufacturer:
UCB S.A., Chemin du Foriest, Braine-l’Alleud, Brussels, Belgium
Product:
Keppra
Product:
Active Ingredient:
Levetiracetam 500mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Muir Hutchison Limited
Manufacturer:
UCB S.A., Chemin du Foriest, Braine-l’Alleud, Brussels, Belgium
Product:
Keppra
Product:
Active Ingredient:
Levetiracetam 750mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Muir Hutchison Limited
Manufacturer:
UCB S.A., Chemin du Foriest, Braine-l’Alleud, Brussels, Belgium
Product:
Relestat
Active Ingredient:
Epinastine hydrochloride 0.5mg/mL
Dosage Form:
Eye drops, solution
New Zealand Sponsor:
Allergan New Zealand Limited
Manufacturer:
Allergan Pharmaceuticals Ireland, Westport, County Mayo, Ireland
Product:
Reminyl Prolonged Release Capsules (Combination Starter Pack)
Active Ingredient:
Galantamine hydrobromide 10.25mg equivalent to 8mg galantamine base
Dosage Form:
Capsule
Active Ingredient:
Galantamine hydrobromide 20.51mg equivalent to 16 mg galantamine base
Dosage Form:
Capsule
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturer:
Janssen-Cilag SpA, Borgo San Michele, Latina, Italy
Product:
Reminyl Prolonged Release Capsules
Active Ingredient:
Galantamine hydrobromide 20.51mg equivalent to 16mg galantamine base
Dosage Form:
Modified release capsule
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturer:
Janssen-Cilag SpA, Borgo San Michele, Latina, Italy
Product:
Reminyl Prolonged Release Capsules
Active Ingredient:
Galantamine hydrobromide 30.76mg equivalent to galantamine base 24mg
Dosage Form:
Modified release capsule
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturer:
Janssen-Cilag SpA, Borgo San Michele, Latina, Italy
Product:
Reminyl Prolonged Release Capsules
Active Ingredient:
Galantamine hydrobromide 10.25mg equivalent to galantamine base 8mg
Dosage Form:
Modified release capsule
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturer:
Janssen-Cilag SpA, Borgo San Michele, Latina, Italy
Product:
Yasmin
Active Ingredients:
Drospirenone 3mg
Ethinyloestradiol 30µg
Dosage Forms:
21 active film coated tablets
7 inactive film coated tablets
New Zealand Sponsor:
Schering (NZ) Limited
Manufacturer:
Schering GmbH und Co Produktions KG, Weimar, Germany
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2004, No 175
Gazette.govt.nz —
NZ Gazette 2004, No 175
✨ LLM interpretation of page content
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social WelfareMedicines, New Medicines, Consent, Hemohes, Keppra, Levetiracetam, Relestat, Reminyl, Yasmin